---
figid: PMC8107720__fphar-12-633453-g005
figtitle: Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer
organisms:
- NA
pmcid: PMC8107720
filename: fphar-12-633453-g005.jpg
figlink: /pmc/articles/PMC8107720/figure/F5/
number: F5
caption: Drug resistance mechanism induced by FGF19/FGFR4. Novel activators act on
  FGF19/FGFR4, which then activates GSK3β/β-catenin with the STAT3 pathway and confers
  drug resistance to cells.
papertitle: Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer.
reftext: Yanan Liu, et al. Front Pharmacol. 2021;12:633453.
year: '2021'
doi: 10.3389/fphar.2021.633453
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: FGFR4 | FGF19 | cancer | activator | inhibitor
automl_pathway: 0.9618853
figid_alias: PMC8107720__F5
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8107720__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8107720__fphar-12-633453-g005.html
  '@type': Dataset
  description: Drug resistance mechanism induced by FGF19/FGFR4. Novel activators
    act on FGF19/FGFR4, which then activates GSK3β/β-catenin with the STAT3 pathway
    and confers drug resistance to cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATF4
  - APEH
  - FGF19
  - FGFR4
  - GSK3B
  - STAT3
---
